- Description
- Table of Contents
- Request Sample
The Melanoma Treatment market is expected to reach $9.70 billion by 2026 growing at a CAGR of 14.6% during 2018 to 2026. Melanoma is a type of skin cancer that develops in the melanocyte cells that are responsible for producing melanin, the pigment responsible for imparting colour to the skin. It occurs when unrepaired damage to skin cells leads to their rapid multiplication, thus forming malignant tumours. The primary cause of Melanoma is prolonged exposure to ultraviolet light. If detected and treated at an early stage, the disease is almost always curable. Its treatment includes radiation therapy, biological therapy and many other options. Factors such as the increase in the number of melanoma cases reported, growing health awareness among people, and environmental changes are driving the market growth. Though, side effects related to the treatment procedures restrain the market growth. Moreover, increase in the number of Food and Drug Administration’s fast track approval and extensive adoption of novel therapeutics are the opportunities for the melanoma treatment market. Based on therapy, the targeted therapy segment is going to have a lucrative growth during the forecast period, due to its high efficacy coupled with minimum side effects. The key vendors mentioned are Merck & Co Inc, F. Hoffmann-La Roche Ltd, Novartis AG, Bristol-Myers Squibb, Amgen Inc, Iovance Biotherapeutics Inc, Pfizer Inc, Eisai Co Ltd, GlaxoSmithKline, AVAX Technologies, AstraZeneca, Biogen Idec, Medarex, Reliance Life Sciences, Sanofi, and Roche. Types Covered: • Mucosal Melanoma • Ocular Melanoma • Lentigo Maglina Melanoma • Acral Lentigious • Nodular Melanoma • Superficial Melanoma • Cutaneous Melanoma Therapies Covered: • Chemotherapy • Radiation Therapy • Targeted Therapy • Surgical Treatment • Immunotherapy • Pharmacological Treatment • Biologic Therapy Drugs Covered: • Keytruda • Opdivo • Yervoy • Mekinist+Tafinlar • Cotellic • Imlygic • Generics • Zelboraf Stages Covered: • Stage 0 • Stage I • Stage II • Stage III • Stage IV Applications Covered: • Hospitals and Clinics • Research Centres • Pharmaceutical Companies • Laboratories Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Melanoma Treatment Market, By Type
5.1 Introduction
5.2 Mucosal Melanoma
5.3 Ocular Melanoma
5.4 Lentigo Maglina Melanoma
5.5 Acral Lentigious
5.6 Nodular Melanoma
5.7 Superficial Melanoma
5.8 Cutaneous Melanoma
6 Global Melanoma Treatment Market, By Therapy
6.1 Introduction
6.2 Chemotherapy
6.3 Radiation Therapy
6.4 Targeted Therapy
6.5 Surgical Treatment
6.6 Immunotherapy
6.7 Pharmacological Treatment
6.8 Biologic Therapy
7 Global Melanoma Treatment Market, By Drug
7.1 Introduction
7.2 Keytruda
7.3 Opdivo
7.4 Yervoy
7.5 Mekinist+Tafinlar
7.6 Cotellic
7.7 Imlygic
7.8 Generics
7.9 Zelboraf
8 Global Melanoma Treatment Market, By Stage
8.1 Introduction
8.2 Stage 0
8.3 Stage I
8.4 Stage II
8.5 Stage III
8.6 Stage IV
9 Global Melanoma Treatment Market, By Application
9.1 Introduction
9.2 Hospitals and Clinics
9.3 Research Centres
9.4 Pharmaceutical Companies
9.5 Laboratories
10 Global Melanoma Treatment Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Merck & Co. Inc
12.2 F. Hoffmann-La Roche Ltd
12.3 Novartis AG
12.4 Bristol-Myers Squibb
12.5 Amgen Inc
12.6 Iovance Biotherapeutics Inc
12.7 Pfizer Inc.
12.8 Eisai Co Ltd
12.9 GlaxoSmithKline
12.10 AVAX Technologies
12.11 AstraZeneca
12.12 Biogen Idec
12.13 Medarex
12.14 Reliance Life Sciences
12.15 Sanofi
12.16 Roche
List of Data Tables
Table 1 Global Melanoma Treatment Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Melanoma Treatment Market Outlook, By Mucosal Melanoma (2016-2026) ($MN)
Table 4 Global Melanoma Treatment Market Outlook, By Ocular Melanoma (2016-2026) ($MN)
Table 5 Global Melanoma Treatment Market Outlook, By Lentigo Maglina Melanoma (2016-2026) ($MN)
Table 6 Global Melanoma Treatment Market Outlook, By Acral Lentigious (2016-2026) ($MN)
Table 7 Global Melanoma Treatment Market Outlook, By Nodular Melanoma (2016-2026) ($MN)
Table 8 Global Melanoma Treatment Market Outlook, By Superficial Melanoma (2016-2026) ($MN)
Table 9 Global Melanoma Treatment Market Outlook, By Cutaneous Melanoma (2016-2026) ($MN)
Table 10 Global Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 11 Global Melanoma Treatment Market Outlook, By Chemotherapy (2016-2026) ($MN)
Table 12 Global Melanoma Treatment Market Outlook, By Radiation Therapy (2016-2026) ($MN)
Table 13 Global Melanoma Treatment Market Outlook, By Targeted Therapy (2016-2026) ($MN)
Table 14 Global Melanoma Treatment Market Outlook, By Surgical Treatment (2016-2026) ($MN)
Table 15 Global Melanoma Treatment Market Outlook, By Immunotherapy (2016-2026) ($MN)
Table 16 Global Melanoma Treatment Market Outlook, By Pharmacological Treatment (2016-2026) ($MN)
Table 17 Global Melanoma Treatment Market Outlook, By Biologic Therapy (2016-2026) ($MN)
Table 18 Global Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 19 Global Melanoma Treatment Market Outlook, By Keytruda (2016-2026) ($MN)
Table 20 Global Melanoma Treatment Market Outlook, By Opdivo (2016-2026) ($MN)
Table 21 Global Melanoma Treatment Market Outlook, By Yervoy (2016-2026) ($MN)
Table 22 Global Melanoma Treatment Market Outlook, By Mekinist+Tafinlar (2016-2026) ($MN)
Table 23 Global Melanoma Treatment Market Outlook, By Cotellic (2016-2026) ($MN)
Table 24 Global Melanoma Treatment Market Outlook, By Imlygic (2016-2026) ($MN)
Table 25 Global Melanoma Treatment Market Outlook, By Generics (2016-2026) ($MN)
Table 26 Global Melanoma Treatment Market Outlook, By Zelboraf (2016-2026) ($MN)
Table 27 Global Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 28 Global Melanoma Treatment Market Outlook, By Stage 0 (2016-2026) ($MN)
Table 29 Global Melanoma Treatment Market Outlook, By Stage I (2016-2026) ($MN)
Table 30 Global Melanoma Treatment Market Outlook, By Stage II (2016-2026) ($MN)
Table 31 Global Melanoma Treatment Market Outlook, By Stage III (2016-2026) ($MN)
Table 32 Global Melanoma Treatment Market Outlook, By Stage IV (2016-2026) ($MN)
Table 33 Global Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)
Table 34 Global Melanoma Treatment Market Outlook, By Hospitals and Clinics (2016-2026) ($MN)
Table 35 Global Melanoma Treatment Market Outlook, By Research Centres (2016-2026) ($MN)
Table 36 Global Melanoma Treatment Market Outlook, By Pharmaceutical Companies (2016-2026) ($MN)
Table 37 Global Melanoma Treatment Market Outlook, By Laboratories (2016-2026) ($MN)
Table 38 North America Melanoma Treatment Market Outlook, By Country (2016-2026) ($MN)
Table 39 North America Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 40 North America Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 41 North America Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 42 North America Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 43 North America Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)
Table 44 Europe Melanoma Treatment Market Outlook, By Country (2016-2026) ($MN)
Table 45 Europe Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 46 Europe Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 47 Europe Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 48 Europe Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 49 Europe Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)
Table 50 Asia Pacific Melanoma Treatment Market Outlook, By Country (2016-2026) ($MN)
Table 51 Asia Pacific Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 52 Asia Pacific Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 53 Asia Pacific Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 54 Asia Pacific Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 55 Asia Pacific Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)
Table 56 South America Melanoma Treatment Market Outlook, By Country (2016-2026) ($MN)
Table 57 South America Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 58 South America Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 59 South America Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 60 South America Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 61 South America Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)
Table 62 Middle East & Africa Melanoma Treatment Market Outlook, By Country (2016-2026) ($MN)
Table 63 Middle East & Africa Melanoma Treatment Market Outlook, By Type (2016-2026) ($MN)
Table 64 Middle East & Africa Melanoma Treatment Market Outlook, By Therapy (2016-2026) ($MN)
Table 65 Middle East & Africa Melanoma Treatment Market Outlook, By Drug (2016-2026) ($MN)
Table 66 Middle East & Africa Melanoma Treatment Market Outlook, By Stage (2016-2026) ($MN)
Table 67 Middle East & Africa Melanoma Treatment Market Outlook, By Application (2016-2026) ($MN)